Abstract
Cobalt oxide nanoparticles (Co3O4-NPs) were synthesized using simple urea-based thermal decomposition method. Phase purity and particle size of as-synthesized nanoparticles were characterized through X-ray diffraction pattern (XRD) and transmission electron microscopy. Through XRD morphology of the Co3O4-NPs was found to be variable in size with range of 36 nm. In our present study, we explored the potential cytotoxic and antibacterial effects of Co3O4-NPs in human colorectal types of cancerous cells (HT29 and SW620) and also nine Gram-positive and Gram-negative bacteria. Co3O4-NPs showed promising anticancer activity against HT29 and SW620 cells with IC50 value of 2.26 and 394.5 μg/mL, respectively. However, no significant effect of Co3O4-NPs was observed against bacterial strains. Furthermore, a detailed study has been carried out to investigate the possible mechanism of cell death in HT29 cancer cell line through the analysis of expression level of anti-apoptotic Bcl2 and BclxL markers. Western blot analysis results suggested significant role of Co3O4-NPs exposure in cell death due to apoptosis.
Graphical Abstract
Similar content being viewed by others
References
Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI (2008) ACS Nano 2:889–896
Cheng J, Teply BA, Jeong SY, Yim CH, Ho D, Sherifi I, Jon S, Farokhzad OC, Khademhosseini A, Langer RS (2006) Pharm Res 23:557–564
Schreiber HA, Prechl J, Jiang H, Zozulya A, Fabry Z, Denes F, Sandor M (2010) J Immunol Methods 356:47–59
Wang K, Xu JJ, Chen HY (2005) Biosens Bioelectron 20:1388–1396
Shi R, Chen G, Ma W, Zhang D, Qiu G, Liu X (2012) Dalton Trans 41:5981–5987
Aitken RJ, Chaudhry MQ, Boxall AB, Hull M (2006) Occup Med (Lond) 56:300–306
Shi H, Magaye R, Castranova V, Zhao J (2013) Part Fibre Toxicol 10:15
Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM (1999) Chem Rev 99:3181–3198
Panyam J, Labhasetwar V (2003) Adv Drug Deliv Rev 55:329–347
Rusu VM, Ng CH, Wilke M, Tiersch B, Fratzl P, Peter MG (2005) Biomaterials 26:5414–5426
de la Fuente JM, Berry CC (2005) Bioconjug Chem 16:1176–1180
Maeda H, Bharate GY, Daruwalla J (2009) Eur J Pharm Biopharm 71:409–419
Faraji AH, Wipf P (2009) Bioorg Med Chem 17:2950–2962
Breunig M, Bauer S, Goepferich A (2008) Eur J Pharm Biopharm 68:112–128
Singh R, Lillard JW Jr (2009) Exp Mol Pathol 86:215–223
Papis E, Rossi F, Raspanti M, Dalle-Donne I, Colombo G, Milzani A, Bernardini G, Gornati R (2009) Toxicol Lett 189:253–259
Kumaran RS, Choi YK, Singh V, Song HJ, Song KG, Kim KJ, Kim HJ (2015) Int J Mol Sci 16:7551–7564
Pietruska JR, Liu X, Smith A, McNeil K, Weston P, Zhitkovich A, Hurt R, Kane AB (2011) Toxicol Sci 124:138–148
Siddiqui MA, Alhadlaq HA, Ahmad J, Al-Khedhairy AA, Musarrat J, Ahamed M (2013) PLoS One 8:e69534
Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K (2010) Toxicology 275:65–71
Nygaard UC, Hansen JS, Samuelsen M, Alberg T, Marioara CD, Lovik M (2009) Toxicol Sci 109:113–123
Pelaz B, Charron G, Pfeiffer C, Zhao Y, de la Fuente JM, Liang XJ, Parak WJ, Del Pino P (2013) Small 9:1573–1584
Jun YW, Lee JH, Cheon J (2008) Angew Chem Int Ed Engl 47:5122–5135
Frimpong RA, Hilt JZ (2010) Nanomedicine (Lond) 5:1401–1414
Zhang D, Zhu J, Zhang N, Liu T, Chen L, Liu X, Ma R, Zhang H, Qiu G (2015) Sci Rep 5:8737
Jan E, Byrne SJ, Cuddihy M, Davies AM, Volkov Y, Gun’ko YK, Kotov NA (2008) ACS Nano 2:928–938
Mosmann T (1983) J Immunol Methods 65:55–63
Ahmad R, Raina D, Trivedi V, Ren J, Rajabi H, Kharbanda S, Kufe D (2007) Nat Cell Biol 9:1419–1427
Potoski BA, Mangino JE, Goff DA (2002) Emerg Infect Dis 8:1519–1520
Liang Y, Li Y, Wang H, Zhou J, Wang J, Regier T, Dai H (2011) Nat Mater 10:780–786
Ahmadian S, Barar J, Saei AA, Fakhree MA, Omidi Y (2009) J Vis Exp
Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P (2005) Environ Health Perspect 113:1555–1560
Yang H, Liu C, Yang D, Zhang H, Xi Z (2009) J Appl Toxicol 29:69–78
Klein S, Petersen S, Taylor U, Rath D, Barcikowski S (2010) J Biomed Opt 15:036015
Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL (2014) Part Fibre Toxicol 11:11
Boyoglu C, He Q, Willing G, Barnum S, Dennis VA, Pillai S, Singh SR (2013) ISRN Nanotechnol 2013: 1–13
Newmeyer DD, Bossy-Wetzel E, Kluck RM, Wolf BB, Beere HM, Green DR (2000) Cell Death Differ 7:402–407
Figueroa B Jr, Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ (2004) Biotechnol Bioeng 85:589–600
Ley RE, Peterson DA, Gordon JI (2006) Cell 124:837–848
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Jian M, Zhou Y, Li Y, Zhang X, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD (2010) Nature 464:59–65
Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI (2008) Science 320:1647–1651
Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Nature 474:327–336
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Nature 444:1022–1023
Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, Krajmalnik-Brown R (2009) Proc Natl Acad Sci 106:2365–2370
Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, Nielsen J, Backhed F (2013) Nature 498:99–103
Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Proc Natl Acad Sci 104:13780–13785
Acknowledgments
The authors express gratefulness to the Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have any potential conflict of interest related to current work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
775_2015_1310_MOESM2_ESM.doc
Supplementary material 2 (DOC 2767 kb) Fig. S2 Synthesized Co3O4 napoparticles illustrate negligible antibacterial potential against four Gram-positive (Escherichia coli ATCC-35218, Escherichia coli ATCC-25922, Enterococcus faecalis ATCC-29212, and Bacillus subtilis NCTC-10400 and five Gram-negative bacteria (Staphylococcus aureus ATCC-29213, Pseudomonas aeruginosa ATCC-27853, Shigella sonnei ATCC-11060, Salmonella typhimurium ATCC-13311, and Proteus vulgaris ATCC-6380)) in 250 μg/mL (as indicated by T) concentration with comparison to control drugs Ampicillin: AM and Cefotaxime: CTX (as indicated by C)
Rights and permissions
About this article
Cite this article
Khan, S., Ansari, A.A., Khan, A.A. et al. In vitro evaluation of anticancer and antibacterial activities of cobalt oxide nanoparticles. J Biol Inorg Chem 20, 1319–1326 (2015). https://doi.org/10.1007/s00775-015-1310-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-015-1310-2